An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan

Kuan Der Lee, Hong Hwa Chen, Hwei Ming Wang, Chao Jung Tsao, Tzu Chi Hsu, Chang Fang Chiu, Wu Chou Su, Jeng Yi Wang

研究成果: Article同行評審

2 引文 斯高帕斯(Scopus)

指紋

深入研究「An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan」主題。共同形成了獨特的指紋。

Medicine & Life Sciences